← Back to Clinical Trials
Recruiting NCT04670874

Quality of Life in Cutaneous Lymphoma Patients Using the Skindex29

Trial Parameters

Condition Cutaneous Lymphoma
Sponsor City of Hope Medical Center
Study Type OBSERVATIONAL
Phase N/A
Enrollment 1,250
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2023-08-17
Completion 2034-01-24
Interventions
Quality-of-Life AssessmentQuestionnaire Administration

Brief Summary

This study assesses the quality of life in patients with cutaneous lymphoma diagnosis as it relates to their personal, clinical, and therapeutic information using the Skindex29 questionnaire and also assesses patients' understanding of their diagnosis and need for resources related to their care. Cutaneous lymphomas are a rare type of blood cancers (non-Hodgkin lymphoma) that present in the skin. The information gained from this study, may help researchers improve quality of life in cutaneous lymphoma patients.

Eligibility Criteria

Inclusion Criteria: * Agreement to participate in the research study * Presumed or confirmed diagnosis of CL

Related Trials